Literature DB >> 25541916

Perimetry in young and neurologically impaired children: the Behavioral Visual Field (BEFIE) Screening Test revisited.

Yvonne Koenraads1, Kees P J Braun2, Denise C P van der Linden1, Saskia M Imhof1, Giorgio L Porro1.   

Abstract

IMPORTANCE: Visual field examination in young or neurologically impaired children is a challenge. As a result, the Behavioral Visual Field (BEFIE) Screening Test was developed in 1995.
OBJECTIVES: To evaluate the applicability of the BEFIE test in a large population of young or neurologically impaired children, its reliability and consistency of findings across time, and its potential diagnostic value compared with standard conventional perimetry. DESIGN, SETTING, AND PARTICIPANTS: The BEFIE tests were performed at an academic tertiary center and measured the peripheral visual field extension in degrees by observing an individual's response to a stimulus on a graded arc that moved from the periphery to the center of the visual field along different meridians. Patient files from all children who underwent this test were retrospectively analyzed. In total, 1788 BEFIE tests were performed in 835 children (median age, 3.4 years). MAIN OUTCOMES AND MEASURES: Reliability and results of all tests were longitudinally evaluated. The diagnostic value of the BEFIE test was assessed by comparing monocular BEFIE test results with those of standard conventional perimetry in children who underwent both.
RESULTS: Of 1788 tests, 74% (95% CI, 72%-76%) were considered reliable from the age of 4 months and older, with increasing success with higher ages; 56% reliable in children younger than 1 year; 71% reliable in children between 1 and 2 years; and more than 75% reliable in children 2 years and older (Spearman r = 0.506; P = .11). Peripheral visual field defects were found in 28% (95% CI, 25%-31%) of all first reliable tests. In 75% of children who underwent serial testing, results were consistent and there were good explanations in the case of discrepancies. Comparison of monocular BEFIE tests with standard conventional perimetry results in 147 eyes yielded a positive predictive value of 98% (95% CI, 94%-100%), negative predictive value of 66% (95% CI, 56%-75%), specificity of 98% (95% CI, 95%-100%), sensitivity of 60% (95% CI, 50%-71%), and superior sensitivity of 80% (95% CI, 70%-91%) when only absolute peripheral visual field defects at standard conventional perimetry were accounted for. CONCLUSIONS AND RELEVANCE: These data suggest that the BEFIE test is a valuable tool to detect peripheral visual field defects when standard conventional perimetry cannot be performed in young or neurologically impaired children.

Entities:  

Mesh:

Year:  2015        PMID: 25541916     DOI: 10.1001/jamaophthalmol.2014.5257

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  16 in total

Review 1.  Visual function in children with primary brain tumors.

Authors:  Jason H Peragallo
Journal:  Curr Opin Neurol       Date:  2019-02       Impact factor: 5.710

Review 2.  Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.

Authors:  Emma van der Poest Clement; Floor E Jansen; Kees P J Braun; Jurriaan M Peters
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

Review 3.  Pharmacotherapy for Seizures in Tuberous Sclerosis Complex.

Authors:  Rima Nabbout; Mathieu Kuchenbuch; Catherine Chiron; Paolo Curatolo
Journal:  CNS Drugs       Date:  2021-08-21       Impact factor: 5.749

4.  Ophthalmological Findings in Youths With a Newly Diagnosed Brain Tumor.

Authors:  Myrthe A Nuijts; Inge Stegeman; Tom van Seeters; Marloes D Borst; Carlien A M Bennebroek; Dennis R Buis; Nicole C Naus; Giorgio L Porro; Michelle B van Egmond-Ebbeling; Elisabeth S M Voskuil-Kerkhof; JanWillem R Pott; Niels E Franke; Evelien de Vos-Kerkhof; Eelco W Hoving; Antoinette Y N Schouten-van Meeteren; Saskia M Imhof
Journal:  JAMA Ophthalmol       Date:  2022-10-01       Impact factor: 8.253

5.  Pediatric Perimeter-A Novel Device to Measure Visual Fields in Infants and Patients with Special Needs.

Authors:  PremNandhini Satgunam; Sourav Datta; Koteswararao Chillakala; Karthik R Bobbili; Dhruv Joshi
Journal:  Transl Vis Sci Technol       Date:  2017-07-03       Impact factor: 3.283

6.  Detection and characterisation of visual field defects using Saccadic Vector Optokinetic Perimetry in children with brain tumours.

Authors:  Ian C Murray; Conrad Schmoll; Antonios Perperidis; Harry M Brash; Alice D McTrusty; Lorraine A Cameron; Alastair G Wilkinson; Alan O Mulvihill; Brian W Fleck; Robert A Minns
Journal:  Eye (Lond)       Date:  2018-06-07       Impact factor: 3.775

7.  Study of Optimal Perimetric Testing in Children (OPTIC): Feasibility, Reliability and Repeatability of Perimetry in Children.

Authors:  Dipesh E Patel; Phillippa M Cumberland; Bronwen C Walters; Isabelle Russell-Eggitt; Jugnoo S Rahi
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 8.  Neurofibromatosis: an update of ophthalmic characteristics and applications of optical coherence tomography.

Authors:  Barmak Abdolrahimzadeh; Domenica Carmen Piraino; Giorgio Albanese; Filippo Cruciani; Siavash Rahimi
Journal:  Clin Ophthalmol       Date:  2016-05-13

9.  Feasibility, Accuracy, and Repeatability of Suprathreshold Saccadic Vector Optokinetic Perimetry.

Authors:  Ian C Murray; Lorraine A Cameron; Alice D McTrusty; Antonios Perperidis; Harry M Brash; Brian W Fleck; Robert A Minns
Journal:  Transl Vis Sci Technol       Date:  2016-08-31       Impact factor: 3.283

10.  Gaze-Contingent Flicker Pupil Perimetry Detects Scotomas in Patients With Cerebral Visual Impairments or Glaucoma.

Authors:  Marnix Naber; Carlien Roelofzen; Alessio Fracasso; Douwe P Bergsma; Mies van Genderen; Giorgio L Porro; Serge O Dumoulin
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.